image

Wellness & Health: An industry with a big potential

The once-casual question has taken on a profound twist. Not only because wellness and all kinds of sports activities have become an everyday ritual for young people along with the ever-growing group of “silver agers”. Driven by social media and the many smart devices surrounding us — fitness trackers, phones, smart watches, and other wearables — we measure our health on a daily basis — as an individual and as society.

Together, we generate vast amounts of data which influences our perception of well-being on two levels, personally and in society as a whole. It all relies on an interconnected understanding of our health.

For companies, it opens up a new field for innovation involving the established pharmaceutical industry as well as start-ups.

To the investment idea video

  

 

  

Wellness & Health: An industry with big potential

The once-casual question «How are you today?» has taken on a profound twist. Not only because wellness and all kinds of sports activities have become an everyday ritual for young people along with the ever-growing group of “silver agers”. Driven by social media and the many smart devices surrounding us—fitness trackers, phones, smart watches, and other wearables—we measure our health on a daily basis—as an individual and as a society.

Together, we generate vast amounts of data which influences our perception of well-being on two levels, personally and in society as a whole. It all relies on an interconnected understanding of our health.

For companies, it opens a new field for innovation involving the established pharmaceutical industry as well as start-ups.

Find out in the video with our expert Almasa Cormehic why now is a good time to invest in the industry.

To further expert interviews

  

  

Expert Interviews

image

Interview with Dr. Fabian Unteregger

Dr. Fabian Unteregger is a comedian, entrepreneur and co-founder of the leading Swiss healthcare startup organization Swiss Healthcare Startups and the ETH Circle. In the video interview, he talks about the importance of sleep, balanced diet and exercise for a healthy life. He also emphasizes the opportunities of data diversity in healthcare.

Read more
image

Interview with Etienne Jornod

In May 2020, he stepped down from the position as Executive Chairman of the Board and, together with other partners, bought the Geneva-based biotech company, OM Pharma, from Vifor Pharma. He has held the position of Executive Chairman of the Board of Directors since then. Etienne Jornod is also Honorary Chairman of Galenica and Vifor Pharma as well as Chairman of the Advisory Committee of the University of Lucerne. He talks about the strengths and challenges of the Swiss pharmaceutical industry.

Read more

  

 

Contact us

Your contact is important to us. It is our pleasure to look after you personally and respond to any questions or concerns you have. Simply use the following contact form to send your request and briefly describe your question or issue.

 
  • Legal notice

    The data transmitted to Vontobel using this form are sent encrypted via the Internet. However, the possibility of unauthorized third parties accessing the transmitted data, particularly using malware on the computer, cannot fully be excluded. If you are using this form to send confidential data (e.g. your account number), you accept the risk of disclosure of your banking relationship and bank account information to third parties and you release Vontobel from any and all liability for damages incurred as a result of the use of this form, to the extent that such release is permitted by the law.

    By providing your phone number and/or email address, you declare your express consent to Vontobel contacting you by phone and/or unsecured email. The personal data provided by you are used and stored to handle and process your inquiry and in order for us to perform our contractual duties in connection with the services chosen by you. The personal data may be processed on behalf of Vontobel by a subcontractor engaged by Vontobel, including outside your own or Vontobel’s location. Your personal data are processed and stored for the duration of our business relationship. In addition, we are subject to a number of duties to retain and document. Finally, the duration of storage is also determined by the statutory limitation periods.

    Please note that the use of email and electronic means of communication involves significant risks, such as lack of confidentiality, possible manipulation of contents or sender, dispatch to the wrong recipient, viruses, etc. Vontobel does not accept any responsibility for damages in connection with the use of emails and electronic means of communication. Vontobel therefore also recommends that you do not send sensitive information by email, that received text is not included in responses and that the email address is newly entered manually each time.

    Vontobel does not accept orders for commercial transactions such as the opening of accounts, payment or stock market orders, cancellations of orders or authorizations, blocking of credit cards, changes of address etc. via this form. Please contact your branch or your relationship manager with regard to such transactions.

    The information and/or documents offered on this website represent marketing material pursuant to Art. 68 of the Swiss FinSA and are provided for information purposes only. On request, further documents such as the basic information sheet or the prospectus are available free of charge whenever you wish. The products, services, information, and/or documents offered on this website may not be accessible to individuals domiciled in certain countries. Please note the applicable sales restrictions of the respective products or services.

    Not all products are available in all countries.



    Bank Vontobel AG
    General Counsel
    Gotthardstrasse 43
    CH-8022 Zürich

    Terms and Conditions of Use
    Privacy Policy

 

*

Mandatory information